Kymera
degraders have applicability in serious inflammatory and fibrotic diseases us us us | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2021
Slide
69 of 105
Related slides by other companies
SoftBank
Investor Presentation
February 2024
portfolio companies focused on capital efficient growth as of | SoftBank
AstraZeneca
Investor Day
September 2022
rare disease in years | AstraZeneca
AstraZeneca
Investor Conference
January 2024
i young portfolio of novel blockbuster medicines | AstraZeneca
Pathward Financial
Results
January 2021
i i at i i i i i i a i i a differentiated business lines with growth opportunities significant me revenue | Pathward Financial
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io